← Back
Pendinghealth

New CRISPR variant edits mitochondrial DNA in vivo

Summary

Researchers at the Broad Institute demonstrated a modified CRISPR-Cas13 system capable of editing mitochondrial DNA in living mice, opening treatment pathways for mitochondrial diseases.

Details

Submitter0xf2a3...b4c5
Reputation93
Bond550 PLOT
SubmittedMon, 21 Apr 2025 09:00:00 GMT (10mo ago)
ArweaveNot archived

Sources (1)

https://broadinstitute.org/mito-crispr-2025

Verification Timeline

10mo agoClaim submitted0xf2a3...b4c5
10mo ago550 PLOT bonded0xf2a3...b4c5
10mo ago1 source(s) attached0xf2a3...b4c5